Tianmu Pharmaceutical Industry: Net profit in the first half of 2025 was 10.24 million yuan, turning from a loss to a profit.

Tianmu Pharmaceutical Industry announced that in the first half of 2025, its operating income was 104 million yuan, a year-on-year increase of 73.97%. Net profit was 10.2478 million yuan, compared to a loss of 18.5007 million yuan in the same period last year.